Using CRISPR technology, scientists at U.C. Berkeley have discovered a naturally occurring protein in the lungs that may have the ability to inhibit SARS-CoV-2 infections.
Advanced Technology (CRISPR) Shows That Mucus Is Your Body’s First Line Of Defense Against Viruses
